콘텐츠로 건너뛰기
주식/증권 📈 긍정적

EMCOR Rises 36% in 6 Months: Should Investors Buy the Stock Now?

요약

Can EME's record backlog, healthcare demand and logistics recovery drive its next phase of growth?